About: Obsessive-compulsive disorder

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Obsessive-compulsive disorder Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	Concept
rdfs:label	Obsessive-compulsive disorder
skos:inScheme	http://hub.abes.fr/referentiel/hwpjournalcoll
is Subject of	Cognitive behavioural therapy was effective for adolescent depression after controlling for adverse predictors of outcome Sertraline increased the response rate and improved symptoms in post-traumatic stress disorder The combination of nefazodone and psychotherapy was more effective than either treatment alone in chronic depression The Quick PsychoDiagnostics Panel was accurate for identifying psychiatric disorders in primary care Review: a pooled long term persistence rate of 40% for childhood OCD is lower than previously expected Increasing incidence of some neuropsychiatric disorders in Danish children Review: pharmacotherapy increases response and reduces symptom severity in paediatric anxiety disorders Review: it is unclear whether treating internalising disorders in childhood prevents substance abuse in adolescence Adding repetitive transcranial magnetic stimulation to antidepressants does not improve response in people with depression Sertraline reduced patient dropout rates and acute exacerbation of symptoms in obsessive compulsive disorder Switching serotonin reuptake inhibitors may be of benefit in people with obsessive compulsive disorder Review: cognitive behaviour therapy is beneficial in children with anxiety disorders Tic symptoms in Tourette's syndrome reached their worst level of severity in middle childhood and then declined CBT plus parental anxiety management was more effective when the child and parent(s) were anxious Sertraline improves symptoms in children and adolescents with major depressive disorder Obsessive-compulsive disorder is uncommon but associated with high levels of comorbid neuroses, impaired function and increased suicidal acts in people in the UK Review: no evidence exists that antidepressants acting at >1 pharmacological site differ in efficacy from SSRIs in major depression Fluoxetine may prevent relapse in post traumatic stress disorder Review: in obsessive-compulsive disorder, clomipramine may be more effective than selective serotonin reuptake inhibitors after controlling for other factors Review: clomipramine is more effective than SSRIs for paediatric obsessive compulsive disorder Mental disorders are highly prevalent in Germany Mirtazapine plus citalopram has short term but not longer term benefits over citalopram alone for the symptoms of obsessive compulsive disorder About 30% of men with schizophrenia or schizoaffective disorders have obsessive-compulsive symptoms Major depressive disorder: afternoon and evening diurnal mood variation is common Sertraline was effective in children and adolescents with obsessive compulsive disorder Combination treatment of behaviour therapy and medication significantly reduces obsessive-compulsive symptoms in people who have responded to pharmacotherapy Comorbid OCD, higher score on the MFQ, and older age at presentation predicted persistence of major depression in children and adolescents Plasma exchange and intravenous immunoglobulin improved symptoms in a subtype of obsessive compulsive disorder and tic disorders Anxiety Disorders in Adults. An evidenced-based approach to psychological treatment Exposure and ritual prevention reduces symptoms more than stress management training in OCD treated with SSRIs Review: major anxiety disorders all have substantive familial aggregation Fluoxetine was safe and effective for body dysmorphic disorder Review: Adding SSRIs to antipsychotics does not improve negative symptoms in people with schizophrenia Intensive family-based CBT similarly effective to weekly CBT for paediatric obsessive compulsive disorder Review: antipsychotic augmentation is effective for people with obsessive-convulsive disorder who are receiving, but not responding to, serotonin reuptake inhibitor monotherapy Exposure and response prevention reduced obsessive compulsive disorder symptoms Cognitive treatment reduced concerns about shape, weight, and eating in obese binge and non-binge eaters Review: exposure with response prevention and serotonergic medication reduce symptoms of obsessive-compulsive disorder Lamotrigine for bipolar I disorder improved depressive symptoms on some depression scales Anxiety disorders are a risk factor for suicidal behaviour Review: Antidepressants may increase risk of self-harm or suicidal behaviour in children and adolescents Review: Slow repetitive transcranial magnetic stimulation reduces auditory hallucinations in people with schizophrenia Cognitive behavioural therapy reduced symptoms in patients with obsessive-compulsive disorders with no overt compulsive rituals Risk of several psychiatric disorders was increased in relatives of anorexics and bulimics Fluvoxamine reduced symptoms of social phobia, separation anxiety disorder, and generalised anxiety disorder in children The clinician rated CY-BOCS scale is more sensitive than the self-reported LOI-CV in children and adolescents with obsessive compulsive disorder Group cognitive behavioural therapy increases complete remission of obsessive-compulsive disorder symptoms compared with sertraline, but not response Review: Benefits of antidepressants outweigh risks of suicidal ideation and attempts in children and adolescents

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata